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Maculopathy in
Dengue Fever
To the Editor: A recent article by
Chlebicki et al (1) described 4 patients
hospitalized for dengue fever who
were found to have retinal hemor-
rhages. These patients reported
reduced visual acuity and metamor-
phopsia, i.e., distorted visual images
attributable to intrinsic retinal disease
involving the macula; macular hemor-
rhages and exudates were found on
retinal examination. The authors con-
cluded that the retinal hemorrhages
were responsible for the patients’
visual symptoms.
This conclusion is misleading
because retinal hemorrhages alone
cause scotomas. Rather, the accumu-
lation of subretinal fluid in the macu-
la results in metamorphopsia and
blurring of vision. In previous reports
of patients in whom macular changes
developed from dengue fever, some
were found to have macular hemor-
rhages (2–4). In addition, clinical
examination and investigation of
these patients showed vasculopatho-
logic changes in the macular region
that affected the retinal and choroidal
blood vessels (5), although the tissues
of the periphery tended to be spared.
A fluorescein angiograph of the retina
showed knobby hyperfluorescence of
the retinal arterioles with minimal
leakage, as well as some spots of leak-
age at the level of the retinal pigment
epithelium. An indocyanine green
angiograph showed diffuse hyperfluo-
rescence of the choroid. These patho-
logic changes in the macula were the
most likely cause of the blurring of
vision in such patients, which has
been the case in our experience.
The article by Chlebicki et al. did
not state whether these procedures
had been performed on their patients
to confirm or exclude retinal or
choroidal vasculopathy in the macula.
Therefore, these authors would have
had difficulty concluding that retinal
hemorrhages caused blurring of
vision and metamorphopsia in
patients with dengue maculopathy.
Daniel Hsien-Wen Su* 
and Soon-Phaik Chee*†‡
*Singapore National Eye Centre,
Singapore; †National University of
Singapore, Singapore; and ‡Singapore
Eye Research Institute, Singapore
References
1. Chlebicki MP, Ang B, Barkham T, Laude A.
Retinal hemorrhages in 4 patients with
dengue fever. Emerg Infect Dis.
2005;11:770–2.
2. Wen KH, Sheu MM, Chung CB, Wang HZ,
Chen CW. The ocular fundus findings in
dengue fever [article in Chinese]. Gaoxiong
Yi Xue Ke Xue Za Zhi. 1989;5:24–30. 
3.  Haritoglou C, Scholz F, Bialaslewicz A,
Klauss V. Ocular manifestations in dengue
fever [article in German]. Ophthalmologe.
2000;97:433–6. 
4.  Haritoglou C, Dotse SD, Rudolph G,
Stephan CM, Thurau SR, Klauss V. A
tourist with dengue fever and visual loss.
Lancet. 2002;360:1070.
5. Lim WK, Mathur R, Koh A, Yeoh R, Chee
SP. Ocular manifestations of dengue fever.
Ophthalmology. 2004;111:2057–64.
Address for correspondence: Daniel H-W. Su,
Singapore National Eye Centre, 11 Third
Hospital Ave, Singapore 168751; fax: 65-6226-
3395; email: dannysu22@yahoo.com.sg
Pulmonary
Tuberculosis and
SARS, China 
To the Editor: As part of a cohort
study of 83 patients with severe acute
respiratory syndrome (SARS) in
Beijing, China, we conducted a fol-
low-up study of all the patients by
routine medical examination. During
the process, 3 patients with chest radi-
ographs consistent with active disease
were identified as having pulmonary
tuberculosis (TB). Here we describe
the 1-year clinical outcome and
immune response in these patients. 
Demographic details and coexist-
ing conditions are shown in the Table.
Patient 1 was a healthcare worker who
became infected with SARS-associat-
ed coronavirus (CoV) while on duty
with SARS patients. After he was
transferred to a hospital dedicated to
SARS management, pulmonary TB
was diagnosed (positive acid-fast
bacilli smear on sputum samples).
Patients 2 and 3 were known to have
cases of pulmonary TB and became
infected with SARS-CoV after con-
tact with other patients hospitalized
for SARS. These 2 patients were spu-
tum smear–negative for acid-fast
bacilli, and diagnosis was made on the
basis of previous exposure to TB, rel-
evant symptoms of typical pulmonary
TB, chest radiographs consistent with
active disease, a positive tuberculin
skin test result, and the finding of cav-
ity regression on chest radiographs
after anti-TB treatment was initiated.
No cultures were obtained for isola-
tion and comparison of Myco-
bacterium tuberculosis strains (1). All
3 patients had confirmed SARS based
on amplification of SARS-CoV RNA
by reverse transcriptase–polymerase
chain reaction (RT-PCR) from sputum
and stool specimens (2). Patients 2
and 3 recovered without complica-
tions; patient 1 had the most severe
disease and required mechanical ven-
tilation in an intensive care unit before
recovering.
Both cellular and humoral immu-
nity were evaluated during the follow-
up of these patients. T-lymphocyte
subsets were measured 6 months after
disease onset by flow cytometry using
fluorescein isothiocyanate–labeled
specific monoclonal antibodies.
Compared to other SARS patients (n
= 47), the 3 patients with TB had
lower mean CD4+ T cells (368.4/µL
vs. 656.6/µL, respectively; p = 0.05)
and lower mean CD8+ T cells
(371.0/µL vs. 490.1/µL, respectively;
p = 0.39). SARS-CoV immunoglobu-